Here is the original post: Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
Here is the original post: Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
Originally posted here: QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors
Here is the original post: Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
More: T2 Biosystems Announces Second Quarter 2023 Financial Results
View original post here: Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Go here to read the rest: Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
See the original post here: Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
See the original post here: AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update
See more here: Cellectis Provides Full Report for Second Quarter 2023 Financial Results
View original post here: Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
Recent Comments